Skip to main content

Aroa Soriano Fernández

Institutions of which they are part

Main researcher
Childhood Cancer and Blood Disorders
Vall Hebron Institut de Recerca

Aroa Soriano Fernández

Institutions of which they are part

Main researcher
Childhood Cancer and Blood Disorders
Vall Hebron Institut de Recerca

Projects

Implementation and new biomarker development for Personalised Medicine for Childhood Cancers in Spain

IP: Lucas Moreno Martín-Retortillo
Collaborators: Aroa Soriano Fernández, Marta Garrido Pontnou, Miguel Segura Ginard, Lorena Valero Arrese, Raquel Hladun Alvaro, Elena Antima Martinez Saez, Marta Sese Faustino, Gabriela Guillén Burrieza, Alba Fernández Gómez, Josep Roma Castanyer, Andrea Vilaplana Blanes, Sergio Manresa Vera, Paula Cabre Fernandez, Margarita Ortega Blanco, María Rosario Pérez- Torres Lobato, Asbleidy Carolina Torres Barbosa
Funding agency: Instituto de Salud Carlos III
Funding: 369260
Reference: PMP21/00073
Duration: 01/01/2022 - 31/12/2025

Next generation personalised medicine for childhood cancers

IP: Lucas Moreno Martín-Retortillo
Collaborators: Aroa Soriano Fernández, Jessica Camacho Soriano, Raquel Hladun Alvaro, Gabriela Guillén Burrieza, Andrea Vilaplana Blanes, Paula Cabre Fernandez, Lorena Valero Arrese, Sergio Manresa Vera, Mariona Morell Daniel
Funding agency: Instituto de Salud Carlos III
Funding: 214170
Reference: PI21/01661
Duration: 01/01/2022 - 31/12/2024

Quatsomes as a novel nanomaterial platform for nucleic acids delivery

IP: Miguel Segura Ginard
Collaborators: Soledad Gallego Melcón, Aroa Soriano Fernández, Ariadna Boloix Amenós, Lucas Moreno Martín-Retortillo
Funding agency: Instituto de Salud Carlos III
Funding: 83600
Reference: DTS20/00018
Duration: 01/01/2021 - 31/12/2022

JARC: Joint Action on Rare Cancers Grant Agreement: 724161 VHIR involved in WP9 Task 2 : Objective Use of relevant paediatric preclinical models (patients derived xenografts, genetically modified models, other preclinical model) for experimental

IP: Miguel Segura Ginard
Collaborators: Soledad Gallego Melcón, Aroa Soriano Fernández, Josep Roma Castanyer
Funding agency: Ex. Agency for Health Consumers (EAHC)-CHAFEA
Funding: 6959.28
Reference: JARC_3HP-CHAFEA2015
Duration: 01/10/2016 - 30/09/2019

Related news

Vall d'Hebron presents positive results from two studies in transfusion-dependent thalassaemia and severe bone marrow aplasia at the EBMT Annual Meeting on haematopoietic stem cell transplantation.

La iniciativa "Sin Piedad" explica la història d'en David, un nen que s'està tractant d'un càncer pediàtric, un exemple d'actitud lluitadora davant la malaltia.

The money will allow research into paediatric nervous system tumours and childhood sarcomas to continue, with the aim of improving children's chances of survival and reducing the side effects of treatment.

Related professionals

Maria Carme Altadill Sanchez

Maria Carme Altadill Sanchez

Biomedical Research in Urology
Read more
Alba Sierra Requena

Alba Sierra Requena

Shock, Organ Dysfunction and Resuscitation
Read more
Meritxell Pera Ferreruela

Meritxell Pera Ferreruela

Predoctoral researcher
General Surgery
Read more
Jorge Lunar Roldarn

Jorge Lunar Roldarn

Research technician
Gene Therapy at Nervous System
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.